| Original language | English (US) |
|---|---|
| Pages (from-to) | 1-6 |
| Number of pages | 6 |
| Journal | Urology |
| Volume | 60 |
| Issue number | 3 SUPPL. 1 |
| DOIs | |
| State | Published - Sep 2002 |
| Externally published | Yes |
ASJC Scopus subject areas
- Urology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Overview consensus statement. / Carroll, Peter R.; Kantoff, Philip W.; Balk, Steven P.; Brown, Myles A.; D'amico, Anthony V.; George, Daniel J.; Grossfeld, Gary D.; Johnson, Candace S.; Kelly, William Kevin; Klotz, Laurence; Lee, W. Robert; Lubeck, Deborah P.; Mcleod, David G.; Oh, William K.; Pollack, Alan; Sartor, Oliver; Smith, Matthew R.; Hart, Carol.
In: Urology, Vol. 60, No. 3 SUPPL. 1, 09.2002, p. 1-6.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Overview consensus statement
AU - Carroll, Peter R.
AU - Kantoff, Philip W.
AU - Balk, Steven P.
AU - Brown, Myles A.
AU - D'amico, Anthony V.
AU - George, Daniel J.
AU - Grossfeld, Gary D.
AU - Johnson, Candace S.
AU - Kelly, William Kevin
AU - Klotz, Laurence
AU - Lee, W. Robert
AU - Lubeck, Deborah P.
AU - Mcleod, David G.
AU - Oh, William K.
AU - Pollack, Alan
AU - Sartor, Oliver
AU - Smith, Matthew R.
AU - Hart, Carol
N1 - Funding Information: This supplement and conference were funded by an unrestricted educational grant from AstraZeneca Pharmaceuticals. Myles A. Brown is a paid consultant to, and is a study investigator funded by, Novartis Pharmaceuticals. Daniel J. George is a paid consultant to and a member of the speakers’ bureau for Novartis Pharmaceuticals; a paid consultant to TAP Pharmaceuticals; holds stock in and is on the editorial staff for Veritas Medicine; and is a study investigator funded by Wyeth-Ayerst. William Kevin Kelly is a member of the medical advisory board for Amgen Pharmaceuticals and a member of the speakers’ bureau for AstraZeneca Pharmaceuticals and Bristol-Meyers Squibb. Laurence Klotz is a member of the speakers’ bureau for and a paid consultant to AstraZeneca Pharmaceuticals; a paid consultant to Aventis Pharmaceuticals; and a study investigator funded by Abbott Laboratories Canada. W. Robert Lee is a member of the medical advisory board for Nycomed-Amersham. Deborah P. Lubeck is a study investigator funded by TAP Pharmaceuticals. David G. McLeod is a study investigator funded by AstraZeneca Pharmaceuticals. Alan Pollack is a paid consultant to Amgen Pharmaceuticals, AstraZeneca Pharmaceuticals, and TAP Pharmaceuticals. Oliver Sartor is a paid consultant to and a member of the medical advisory board for Atrix Pharmaceuticals. Matthew R. Smith is a study investigator funded by AstraZeneca Pharmaceuticals and is a paid consultant to and a study investigator funded by Novartis Pharmaceuticals. Copyright: Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2002/9
Y1 - 2002/9
UR - http://www.scopus.com/inward/record.url?scp=18644371958&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=18644371958&partnerID=8YFLogxK
U2 - 10.1016/S0090-4295(02)01559-5
DO - 10.1016/S0090-4295(02)01559-5
M3 - Article
C2 - 12231036
AN - SCOPUS:18644371958
VL - 60
SP - 1
EP - 6
JO - Urology
JF - Urology
SN - 0090-4295
IS - 3 SUPPL. 1
ER -